PRELIMINARY SAFETY ANALYSIS FROM PAC-C STUDY OF CAPECITABINE plus PACLITAXEL -> CAPECITABINE MAINTENANCE (PX-X) VS CAPECITABINE plus CISPLATIN (XP) AS FIRST-LINE CHEMOTHERAPY FOR RECURRENT/METASTATIC GASTRIC CANCER
第一作者机构:[1]Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst,Minist Educ, Dept Gastrointestinal Oncol,Key Lab Carcinogenesi, Beijing 100871, Peoples R China
推荐引用方式(GB/T 7714):
Shen Lin,Zhang Xiaotian,Lu Zhihao,et al.PRELIMINARY SAFETY ANALYSIS FROM PAC-C STUDY OF CAPECITABINE plus PACLITAXEL -> CAPECITABINE MAINTENANCE (PX-X) VS CAPECITABINE plus CISPLATIN (XP) AS FIRST-LINE CHEMOTHERAPY FOR RECURRENT/METASTATIC GASTRIC CANCER[J].ANNALS OF ONCOLOGY.2012,23:43-44.
APA:
Shen, Lin,Zhang, Xiaotian,Lu, Zhihao,Hu, Bing,Fan, Qingxia...&Xu, Nong.(2012).PRELIMINARY SAFETY ANALYSIS FROM PAC-C STUDY OF CAPECITABINE plus PACLITAXEL -> CAPECITABINE MAINTENANCE (PX-X) VS CAPECITABINE plus CISPLATIN (XP) AS FIRST-LINE CHEMOTHERAPY FOR RECURRENT/METASTATIC GASTRIC CANCER.ANNALS OF ONCOLOGY,23,
MLA:
Shen, Lin,et al."PRELIMINARY SAFETY ANALYSIS FROM PAC-C STUDY OF CAPECITABINE plus PACLITAXEL -> CAPECITABINE MAINTENANCE (PX-X) VS CAPECITABINE plus CISPLATIN (XP) AS FIRST-LINE CHEMOTHERAPY FOR RECURRENT/METASTATIC GASTRIC CANCER".ANNALS OF ONCOLOGY 23.(2012):43-44